Ocular Surface Disease

It is autumn on the North Coast. Longer nights lead to deeper insights as we contemplate the winter solstice. As usual, I am thinking dry eye. It is, as they say, how I roll.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

Many patients with ocular surface disease have sought relief at their hometown pharmacies with long-proven, branded lubricants.

July is Dry Eye Awareness Month, but educating patients about symptoms and treatment is critical throughout the year, especially in light of recent data that show many American adults do not know relief is possible.

The Twin Cities Ocular Surface Disease Symposium, Sept. 7 and 8, will feature discussions about dry eye comorbidities, standards of care and more, Ahmad M. Fahmy, OD, FAAO, DiplABO, the event’s founder, told Healio.

NASHVILLE, Tenn. — A clinician shared his experience using Vevye in a post-cataract surgery patient with autoimmune disease in this Healio video at Optometry’s Meeting.

NASHVILLE, Tenn. — A preservative-free brimonidine tartrate ophthalmic solution was statistically noninferior to Bausch + Lomb’s Lumify, offering an alternative option for ocular redness relief, according to a poster at Optometry’s Meeting.

Miss this year’s Real World Ophthalmology meeting? Catch up on the most popular articles from the virtual conference below.

Catch up on the most popular items from Kiawah Eye as Healio’s coverage of the meeting continues.